Science News
from research organizations

Broadly-protective HIV Vaccine May Be Possible

Date:
May 30, 2007
Source:
Henry M. Jackson Foundation for the Advancement of Military Medicine
Summary:
New research suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus. HIV is extremely variable, so an effective vaccine may need to stimulate the body to produce cross-reactive antibodies that will neutralize multiple viral strains. These results demonstrate that induction of truly broad-spectrum neutralizing antibodies may be an achievable goal.
FULL STORY

New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus. HIV is extremely variable, so an effective vaccine may need to stimulate the body to produce cross-reactive antibodies that will neutralize multiple viral strains.

These results demonstrate that induction of truly broad-spectrum neutralizing antibodies may be an achievable goal. 

To be effective, an HIV vaccine must induce the body to produce cross-reactive antibodies that can neutralize multiple strains. USU Professors CAPT Gerald Quinnan, Jr., M.D., USPHS, and Christopher Broder, Ph.D., and their colleagues at USU attempted to elicit these broad-range antibodies in an animal model by immunizing with a particular HIV-1 surface protein, designated R2 gp140, and an immune response-boosting component.

The researchers tested antibodies generated by the immunizations to determine their effectiveness in neutralizing the infectivity of a variety of HIV-1 strains. Antibodies produced as a result of immunization neutralized all 48 strains of HIV-1 tested. The results are encouraging for vaccine development, because they showed that it is possible to elicit a broad-spectrum antibody response.

This research was supported by a grant from a number of collaborators including the National Institutes of Health/NIAID and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Article: "Extensively Cross-Reactive Anti-HIV-1 Neutralizing Antibodies Induced by gp140 Immunization" appears in the Proceedings of the National Academy of Sciences http://www.pnas.org/papbyrecent.shtml.


Story Source:

The above post is reprinted from materials provided by Henry M. Jackson Foundation for the Advancement of Military Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Henry M. Jackson Foundation for the Advancement of Military Medicine. "Broadly-protective HIV Vaccine May Be Possible." ScienceDaily. ScienceDaily, 30 May 2007. <www.sciencedaily.com/releases/2007/05/070529162608.htm>.
Henry M. Jackson Foundation for the Advancement of Military Medicine. (2007, May 30). Broadly-protective HIV Vaccine May Be Possible. ScienceDaily. Retrieved May 1, 2016 from www.sciencedaily.com/releases/2007/05/070529162608.htm
Henry M. Jackson Foundation for the Advancement of Military Medicine. "Broadly-protective HIV Vaccine May Be Possible." ScienceDaily. www.sciencedaily.com/releases/2007/05/070529162608.htm (accessed May 1, 2016).